SOME diseases are so devastating that survival is virtually impossible – with fatality rates hitting 100 per cent. Thankfully, due to modern medicine, they’re incredibly rare. The few that ...
Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...
A study of more than 26,000 white dwarf stars has confirmed a long-predicted but elusive effect in these ultra-dense, dying stars: Hotter white dwarfs are slightly puffier than cooler ones, even when ...